2022 - Research.com Best Scientist Award
His primary areas of investigation include Medulloblastoma, Cancer research, Bioinformatics, Genetics and Pathology. His Medulloblastoma study combines topics in areas such as Cancer, Clinical trial, Gene expression profiling, Genomics and Human genetics. Stefan M. Pfister has included themes like Mutation, IDH1, Epigenetics and Exome in his Cancer research study.
His Exome study combines topics from a wide range of disciplines, such as APOBEC, Kataegis, Cytidine deaminase and DNA mismatch repair. His Bioinformatics research is multidisciplinary, relying on both Survival rate and Retrospective cohort study. As part of the same scientific family, Stefan M. Pfister usually focuses on Pathology, concentrating on Young adult and intersecting with Stage, Extent of resection, Predictive value of tests, Cytogenetics and Patient age.
The scientist’s investigation covers issues in Cancer research, Medulloblastoma, Pathology, DNA methylation and Internal medicine. His Cancer research research is multidisciplinary, incorporating perspectives in Mutation, Histone, Gene and Carcinogenesis. His Medulloblastoma study incorporates themes from Cancer, Wnt signaling pathway, Bioinformatics, Gene expression profiling and Sonic hedgehog.
He interconnects Transcriptome, Disease and Genomics in the investigation of issues within Bioinformatics. His DNA methylation study results in a more complete grasp of Genetics. His Internal medicine study which covers Oncology that intersects with Cohort.
Stefan M. Pfister mainly investigates Cancer research, DNA methylation, Internal medicine, Medulloblastoma and Oncology. His studies examine the connections between Cancer research and genetics, as well as such issues in Epigenetics, with regards to Gene mutation. His study in DNA methylation is interdisciplinary in nature, drawing from both Methylation, DNA and Sarcoma, Pathology.
His study looks at the intersection of Sarcoma and topics like Epigenomics with Cancer. His research integrates issues of Ependymoma and MEDLINE in his study of Internal medicine. The various areas that he examines in his Medulloblastoma study include Suppressor, Transcriptome, Germline and Sonic hedgehog, PTCH1.
His scientific interests lie mostly in Cancer research, Internal medicine, DNA methylation, Medulloblastoma and Oncology. His Cancer research research includes themes of Mutation, Histone H3, Chemotherapy and Carcinogenesis. His work deals with themes such as Methylation profiling and MEDLINE, which intersect with Internal medicine.
His work investigates the relationship between DNA methylation and topics such as Pathology that intersect with problems in Methylation, Gene panel, YAP1 and YWHAE. His Medulloblastoma research includes elements of Germline mutation, Transcriptome, Germline, Disease and PTCH1. His studies deal with areas such as Craniospinal Irradiation, Disease specific and Glioma as well as Oncology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio.
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Molecular Subgroups of Medulloblastoma: The Current Consensus
Michael D. Taylor;Paul A. Northcott;Andrey Korshunov;Marc Remke;Marc Remke.
Acta Neuropathologica (2012)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott;Andrey Korshunov;Hendrik Witt;Thomas Hielscher.
Journal of Clinical Oncology (2011)
Replicative senescence of mesenchymal stem cells: a continuous and organized process.
Wolfgang Wagner;Patrick Horn;Mirco Castoldi;Anke Diehlmann.
PLOS ONE (2008)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)
DNA methylation-based classification of central nervous system tumours
David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: